933988-24-0 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
2-(3-Fluorophenyl)pyrimidine-5-carboxylic acid is used as a pharmaceutical compound for its potential therapeutic effects on various diseases and disorders. It has been studied for its potential use in treating conditions such as cancer and inflammation, where its unique structure may contribute to its medicinal action.
Used in Organic Synthesis:
In the field of organic chemistry, 2-(3-Fluorophenyl)pyrimidine-5-carboxylic acid serves as a building block for the preparation of other compounds. Its versatile structure allows it to be a key component in the synthesis of a wide range of chemical entities, expanding its utility beyond direct medicinal applications.
Used in Cancer Treatment Research:
2-(3-Fluorophenyl)pyrimidine-5-carboxylic acid is used as a research compound in the development of cancer treatments. Its potential to target specific biological pathways involved in cancer progression makes it a valuable candidate for further investigation and possible incorporation into novel therapeutic agents.
Used in Inflammation Management Research:
2-(3-Fluorophenyl)pyrimidine-5-carboxylic acid is also used in research aimed at managing inflammation. Given its structural features, it may have the capacity to modulate inflammatory responses, offering a new avenue for the treatment of inflammatory diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 933988-24-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,9,8 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 933988-24:
(8*9)+(7*3)+(6*3)+(5*9)+(4*8)+(3*8)+(2*2)+(1*4)=220
220 % 10 = 0
So 933988-24-0 is a valid CAS Registry Number.
933988-24-0Relevant articles and documents
PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS
-
Page/Page column 62, (2008/12/04)
This invention is directed to a compound wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS
-
Page/Page column 37, (2010/11/26)
This invention is directed to a compound of formula (I): wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).